Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.82%43.19B | -10.22%40.81B | -14.36%9.5B | -3.81%10.45B | -21.15%10.61B | 2.05%10.25B | 12.39%45.46B | 0.03%11.09B | 0.53%10.86B | 40.97%13.46B |
| Cost of revenue | 4.05%34.61B | -11.45%33.26B | -17.80%7.76B | -4.28%8.28B | -22.06%8.67B | 2.43%8.56B | 12.17%37.56B | 2.32%9.44B | -3.55%8.65B | 40.73%11.12B |
| Gross profit | 13.63%8.58B | -4.41%7.55B | 5.27%1.74B | -2.03%2.17B | -16.80%1.95B | 0.18%1.69B | 13.46%7.9B | -11.33%1.65B | 20.41%2.22B | 42.02%2.34B |
| Operating expense | 13.26%5.98B | 6.50%5.28B | 17.07%1.3B | 9.93%1.44B | -3.08%1.26B | 3.40%1.28B | 1.45%4.96B | -13.72%1.11B | 5.48%1.31B | 9.72%1.3B |
| Operating profit | 14.48%2.6B | -22.77%2.27B | -19.11%436M | -19.25%734M | -33.91%688M | -8.61%414M | 41.71%2.94B | -5.93%539M | 51.25%909M | 124.35%1.04B |
| Net non-operating interest income (expenses) | 100.00%60M | 433.33%30M | 2,200.00%21M | 300.00%4M | 200.00%4M | 150.00%1M | 18.18%-9M | 66.67%-1M | 0.00%-2M | 0.00%-4M |
| Non-operating interest income | 33.00%133M | 92.31%100M | 143.75%39M | 61.54%21M | 83.33%22M | 63.64%18M | 20.93%52M | 33.33%16M | 18.18%13M | 20.00%12M |
| Non-operating interest expense | 4.29%73M | 14.75%70M | 5.88%18M | 13.33%17M | 12.50%18M | 30.77%17M | 12.96%61M | 13.33%17M | 15.38%15M | 14.29%16M |
| Net investment income | -83.81%120M | 35.47%741M | 3,344.44%310M | 16.27%-283M | -34.16%293M | -2.32%421M | 31.49%547M | -96.14%9M | -431.37%-338M | 867.39%445M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -36.00%16M | 25M | 27M | 1M | 0 | -3M | 0 | 0 | 0 | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -410.53%-59M | 100.91%19M | 92.65%-148M | 130.53%29M | 15.63%37M | 2,625.00%101M | -4,233.33%-2.08B | -3,370.69%-2.01B | -763.64%-95M | -21.95%32M |
| Less:Other special charges | -5.45%-174M | -107.93%-165M | -99.90%2M | -130.53%-29M | -15.63%-37M | -2,625.00%-101M | 4,233.33%2.08B | 3,370.69%2.01B | 763.64%95M | 21.95%-32M |
| Less:Write off | 59.59%233M | --146M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 625.00%29M | -96.12%4M | -5,700.00%-58M | -59.57%19M | -41.03%23M | 11.11%20M | 53.73%103M | -104.17%-1M | 370.00%47M | 333.33%39M |
| Income before tax | -10.51%2.77B | 106.27%3.09B | 140.10%589M | -3.28%502M | -32.65%1.05B | 6.58%955M | -40.06%1.5B | -291.03%-1.47B | -26.80%519M | 183.91%1.55B |
| Income tax | 3.62%573M | -35.02%553M | 2.00%204M | -4,766.67%-140M | -36.16%226M | -10.54%263M | 54.17%851M | 185.71%200M | -98.20%3M | 139.19%354M |
| Net income | -13.55%2.19B | 292.27%2.54B | 123.01%384M | 24.85%643M | -31.75%819M | 15.14%692M | -66.80%647M | -338.43%-1.67B | -4.98%515M | 201.51%1.2B |
| Net income continuous operations | -13.59%2.19B | 291.82%2.54B | 123.07%385M | 24.42%642M | -31.61%820M | 14.95%692M | -66.75%648M | -338.77%-1.67B | -4.80%516M | 200.50%1.2B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -13.55%2.19B | 292.27%2.54B | 123.01%384M | 24.85%643M | -31.75%819M | 15.14%692M | -66.80%647M | -338.43%-1.67B | -4.98%515M | 201.51%1.2B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -13.55%2.19B | 292.27%2.54B | 123.01%384M | 24.85%643M | -31.75%819M | 15.14%692M | -66.80%647M | -338.43%-1.67B | -4.98%515M | 201.51%1.2B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -11.89%270.78 | 297.27%307.33 | 123.82%47.51 | 27.74%78.69 | -31.32%98.44 | 15.05%82.69 | -66.78%77.36 | -338.69%-199.45 | -4.88%61.6 | 201.32%143.34 |
| Diluted earnings per share | -11.89%270.78 | 297.27%307.33 | 123.59%47.0464 | 27.88%78.69 | -31.32%98.44 | 15.05%82.69 | -66.78%77.36 | -338.69%-199.45 | -4.97%61.5359 | 201.45%143.34 |
| Dividend per share | 50.00%90 | 9.09%60 | 9.09%60 | 0 | 0 | 0 | 22.22%55 | 22.22%55 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |